DRTS News and Press, Alpha Tau Medical Ltd. From 05/23/22

First Alpha DaRT Patients Treated in France as Part of Alpha DaRT™ Multicenter Skin Cancer Trial PR Newswire JERUSALEM , May 23, 2022 /PRNewswire/ -- Alpha Tau Medical (Nasdaq: DRTS) (Nasdaq: DRTSW) , the developer of the pioneering alpha-r...

Medical device maker Alpha Tau (DRTS) saw its stock rally 17% on Thursday after several days of decline. Shares of DRTS opened at $4.89. The stock recently changed hands at $6.05, up 17%, at approximately $12:00 p.m. ET. DRTS stock had declined significantly since last week, with the shares l...

Medtech Alpha Tau Medical (DRTS) stock slid 12% Friday after rallying 20% in the previous session. Alpha Tau (DRTS) shares opened at $9.97, rising to a session high of $10.21 before sinking to a low of $8.47 in mid-afternoon. The stock closed at $8.92, down 12%. The medical device maker made ...

Gainers: Cyngn (CYN) +70%. Sky Harbour Group (SKYH) +28%. Redbox Entertainment (RDBX) +25%. Wrap Technologies (WRAP) +18%. Inozyme Pharma (INZY) +16%. MedAvail Holdings (MDVL) +14%. Red Cat Holdings (OTCQB:RCAT) +13%. Pulse Biosciences (PLSE) +12%. United Airlines Holdings (UAL) +11%. Alpha T...

Alpha Tau Medical’s proprietary Alpha DaRT device safely delivers alpha radiation with localized precision to treat cancers. Alpha Tau is waiting for FDA feedback to initiate a US pivotal trial in 1H-2022. DRTS recently merged with SPAC Healthcare Capital infusing fresh cap...

The shares of Israeli medical device company Alpha Tau Medical (DRTS +13.1%) have ended a three-day slide after Citi started its coverage with a Buy recommendation highlighting the prospects of its alpha radiation-based cancer therapy, Alpha DaRT. Comparing alpha radiation with beta or gamma ...

Alpha Tau Medical press release (NASDAQ:DRTS): FY GAAP EPS of -$0.67. As of December 31, 2021, cash and cash equivalents and deposits in the amount of $31.9 million, compared to $46.6 million at December 31, 2020. Shares +3% PM For further details see: ...

Alpha Tau Medical Announces Full Year 2021 Financial Results and Provides Corporate Update -Debuted as publicly-traded oncology company in March 2022 under symbol DRTS while raising approximately $90 million in gross proceeds- -100% complete response (CR) observed in U.S. mu...

Gainers: Clever Leaves (CLVR) +28%. Tilray Brands (TLRY) +13%. Cutera (CUTR) +11%. STRATA Skin Sciences (SSKN) +10%. Clarus Therapeutics (CRXT) +8%. Losers: MEI Pharma (MEIP) -58%. Icosavax (ICVX) -50%. Rezolute (RZLT) -9%. Alpha Tau Medical (...

Shares of Alpha Tau Medical (NASDAQ: DRTS) were skyrocketing 23.9% as of 3:26 p.m. ET on Thursday. Trading of the stock was even halted temporarily as part of the market "circuit-breaker" triggers. The company didn't announce any news, however. Today's move appears to be a conti...